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ABSTRACT
Objective: Knema attenuata (Myristicaceae), popularly known as “wild nutmeg,” is an endemic tree species from Western Ghats, which has been 
used in folk medicine. Conventionally, the stem bark of K. attenuata is used for treating inflammatory conditions without any scientific information 
available for the same. The present study was undertaken to evaluate the anti-inflammatory activity of the ethanolic stem bark extract (ESBE) of 
K. attenuata using in vivo and in vitro screening models.
Methods: The ethanolic extract of stem bark was prepared by soxhlation, and its cytotoxicity in RAW 264.7 cell line was assessed using MTT assay 
method. In vivo anti-inflammatory effect of extract was estimated in rats using carrageenan-induced paw edema model and cotton pellet-induced 
granuloma model. The in vitro anti-inflammatory activity of the extract was evaluated by cyclooxygenase and lipoxygenase inhibition assay, 
estimation of myeloperoxidase activity, and determination of cellular nitrite levels in lipopolysaccharide-stimulated RAW 264.7 macrophage 
cells.
Results: Toxic symptoms were not observed for the ESBE. The extract demonstrated significant anti-inflammatory activity in both in vivo and in vitro 
models. The anti-inflammatory action exhibited by the extract was a result of the inhibition of leukocyte migration and nitric oxide pathway and 
partially by inhibition of mediators such as prostaglandins and leukotrienes.
Conclusion: Findings from the study provide the evidence for the popular use of stem bark extract of K. attenuata as a potential anti-inflammatory 
agent.
Keywords: Knema attenuata, Folk use, anti-inflammatory activity, Carrageenan-induced paw edema.
INTRODUCTION
Inflammation is a protective biological response of body toward tissue 
injury or infection. Inflammatory mediators such as prostaglandins, 
histamine, lysosomal enzymes, leukotrienes, bradykinin, and 
cytokines amplify the inflammatory response to remove the 
harmful stimuli [1]. Inflammatory response can be either acute or 
chronic. Acute inflammation is the initial response to eliminate the 
causative agent, and when it fails to resolve, chronic inflammation is 
established [2,3]. Chronic inflammation, associated with increased 
free radical production, is involved in the pathogenesis of various 
diseases such as diabetes, lipid dysregulation, arthritis, and cardiac 
disorders [4,5]. Nowadays, the usage of synthetic drugs dominates the 
medicinal market for treating inflammatory conditions. However, their 
prolonged administration may provoke adverse effects such as gastric 
irritation and cardiac complications [6,7]. This initiates the need for 
searching an efficient and safe complimentary medicine. The bioactive 
compounds isolated from medicinal plants that exhibit potent anti-
inflammatory activity can be one of the reliable sources that serve the 
purpose [8].
Knema attenuate (Myristicaceae), commonly known as “wild nutmeg,” 
is an endemic tree species native to southern India extending from 
Konkan southward of Maharashtra, Goa, Karnataka, Tamil Nadu, and 
Kerala [9]. This species has been used in folk medicine as an ingredient 
of ayurvedic “Ashwagandhadi nei,” for the treatment of conditions 
such as spleen disorders, breathing disorders, and impaired taste 
sensation. The stem bark is also being used in the form of decoction for 
the treatment of jaundice and chronic fever [10]. Studies on the stem 
bark of K. attenuata reported the presence of a lignan attenuol; closely 
related to lignans isolated from the plants of Myristicaceae family [11]. 
Lignans are a large group of compounds, which exhibit antioxidant, 
liver protection, anti-inflammatory, and anticancerous properties [12]. 
In addition, the presence of a common constituent anacardic acid 
has been reported in plants under genus Knema, which possesses 
antibacterial, anticancer, and anti-inflammatory properties [13]. 
However, scientific data on the pharmacological screening in the stem 
bark of K. attenuata are not available till date. Therefore, the present 
study was designed to evaluate the anti-inflammatory potential of 
ethanolic stem bark of K. attenuata using both in vivo and in vitro 
screening techniques.
MATERIALS AND METHODS
Plant material and extract preparation
The stem bark of K. attenuata for the proposed study was collected from 
Kerala Forest Research Institute, Peechi and Thrissur in the month of 
January 2015. The plant material was taxonomically identified and 
authenticated by Dr. VB Sreekumar, Scientist (Botany Department), 
Kerala Forest Research Institute, Peechi, Thrissur. The fresh stem bark 
was thoroughly washed, spread in trays, and air dried for 3 weeks. 
The dried stem bark was then powdered and sieved (sieve no: 44) for 
extraction.
The stem bark powder of K. attenuata (50 g) was packed in a thimble 
and loaded in a Soxhlet apparatus. After defatting stem bark powder 
with petroleum ether (60–80°C), it was subjected to continuous 
extraction with 300 ml of 95% ethanol. Excess solvent was recovered by 
vacuum evaporation (at 40°C) to obtain the dried ethanolic stem bark 
extract (ESBE) with a percentage yield of 17.8% w/w [14].
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i4.30500
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Animals
Wistar rats of either sex (150–250 g) procured from animal house 
(Reg. No: 752/02/a/CPCSEA) of Government Medical College, 
Trivandrum, were used for the studies. The animals were housed 
in propylene cages (three per cage) with dust-free husk as bedding 
material under standard condition of temperature (25±2°C) and 
relative humidity (30–70%) with a 12:12 light-dark cycle and fed 
with standard rodent pellet and water except during experimentation. 
Institutional Animal Ethics Committee, Government Medical College, 
Thiruvananthapuram, approved the experimental protocols on 
17/12/2014 (Approval no: 03/13/2014/MCT).
Cell culture
RAW 264.7 macrophage cells were cultured in DMEM, supplemented 
with 10% heat-inactivated fetal bovine serum, antibiotics (penicillin 
and streptomycin; 100 μg/ml each), and 1.5% sodium bicarbonate. The 
cell lines were maintained under a temperature of 37°C in a humidified 
atmosphere of 5% CO2 [15].
Cell viability assay
RAW 264.7 cells at a density ×2 104 cells/well were seeded on a 96-well 
microplate containing media. After overnight incubation, the media 
from each well were removed, and fresh media were placed with or 
without ESBE at concentration range of 6.25–100 µg/ml. After 24 h of 
incubation, the media were replaced, and MTT (50 μl) was added to cells, 
which were then incubated for 4 h at 37°C. The media were removed, 
and the MTT-formazan crystals were solubilized in dimethyl sulfoxide. 
Absorbance was recorded at 570 nm, and IC50 was calculated [16].
In vivo pharmacological studies
Anti-inflammatory assays
Grouping of animals
Wistar rats of either sex (150–250 g) were randomly divided into four 
groups with each groups consisting of six animals.
Animals of Group 1 (control) received water, animals of Group 2 received 
standard drug (carrageenan-induced paw edema: Indomethacin 
10 mg/kg; cotton pellet-induced granuloma: Dexamethasone 
10 mg/kg), animals of Group 3 received ESBE 250 mg/kg, and animals 
of Group 4 received ESBE 500 mg/kg orally.
Carrageenan-induced paw edema in rat
Edema was induced by injecting 0.05 ml of 1% solution of carrageenan 
in 0.9% normal saline solution subcutaneously into the plantar 
region of left hind paw of each animal of all the groups. Their paw 
volumes were measured plethysmographically at 0, 1, 2, 3, and 4 h 
after carrageenan challenge. The percentage increase in paw volume 
was calculated. The difference of average values between treated 
animals and control group was calculated for each time interval and 
statistically analyzed.
Percentage inhibition of edema = ((C−D)/C)−100
C - Percentage difference in paw volume of control group.
D - Percentage difference in paw volume of drug-treated group [17].
Cotton pellet granuloma method
Rats were anesthetized and their axillary skin was shaved and 
disinfected with 70% ethanol. Subcutaneous tunnel was created 
on the axilla region using a blunted forceps, and a sterilized cotton 
pellet weighing 50±1 mg was implanted there, with the help of sterile 
instruments after which tunnels were stitched and closed. After 24 h 
of implantation, each animal group was treated orally with vehicle, 
standard or test drug continuously for 7 days. The animals were 
sacrificed, and the cotton pellets (along with granular tissue formed 
around) were removed on the 8th day. The pellets were dried in an 
incubator at 60°C until they showed a stable weight. The percentage 
inhibition of granuloma formation was calculated using formula:
Percentage inhibition of dry weight of granuloma formation = 
100[(A−B)/A]
Where
A = Gain in dry weight of control pellets
B = Gain in dry weight of standard or test treated pellets [18].
In vitro pharmacological studies
Anti-inflammatory activity in cell lines
Raw 264.7 cells were grown to 60% confluence (log phase) followed 
by activation with lipopolysaccharide (LPS) (1 μg/ml). LPS-stimulated 
cells were exposed to different concentrations (6.25 µg/ml, 12.5 µg/ml, 
25 µg/ml, 50 µg/ml, and 100 µg/ml) of ESBE and incubated for 24 h. After 
incubation, cell lysate was prepared using which the anti-inflammatory 
assays were performed [19].
Cyclooxygenase (COX) inhibitory assay
The assay mixture contained Tris-HCl buffer, glutathione, hemoglobin, 
and enzyme contained in sample. The reaction was started by the 
addition of arachidonic acid and terminated after 20 min of incubation 
at 37°C by the addition of 0.2 ml of 10% trichloroacetic acid in 1N HCl, 
mixed, and 0.2 ml of TBA was added, and contents were heated in a 
boiling water bath for 20 min, cooled, and centrifuged at 1000 rpm for 
3 min. The supernatant was measured at 632 nm for COX activity. The 
extent of inhibition was calculated using the following formula:
Percentage inhibition = ((C−T)/C)×100
C = Optical density of control; T = Optical density of test [20].
Lipoxygenase (LOX) inhibitory assay (assay of 5-lipoxygenase)
For this test, 70 mg of linoleic acid and equal weight of tween 20 
was dissolved in 4 ml of oxygen-free water and mixed back and forth 
with a pipette avoiding air bubbles. Sufficient amount of 0.5 N NaOH 
was added to yield a clear solution and then made up to 25ml using 
oxygen-free water. This was divided into 0.5 ml portions and flushed 
with nitrogen gas before closing and kept frozen until needed. The 
reaction was carried out in a quartz cuvette at 25°C with 1 cm light 
path. The assay mixture contains 2.75 ml tris buffer with a pH of 7.4, 
0.2 ml of sodium linoleate, and 50 µl of the enzyme. The increase in 
optical density was measured in 234 nm. The extent of inhibition was 
calculated using the formula:
Percentage inhibition = ((C−T)/C)×100
C = Optical density of control; T = Optical density of test [21].
Estimation of myeloperoxidase (MPO) enzyme activity
Cultured sample was mixed in a solution containing 50 mM KH2PO4/
K2HPO4 buffer (pH 6) and 0.57 ml hexadecyl trimethyl ammonium 
bromide. The samples were centrifuged at 2000 rpm for 30 min at 4°C, 
and resulting supernatant was assayed using a spectrophotometer 
for MPO. Sample was mixed with 50 mM phosphate buffer (pH=6) 
containing 1.67 mg/ml guaiacol and 0.0005% hydrogen peroxide. 
The change in absorbance at 490 nm was measured. MPO activity 
was expressed in units/mg tissue. One unit of MPO activity = 1 milli 
moleperoxide degraded per minute at 25°C [19].
Estimation of cellular nitrite levels
The concentration of nitrite was estimated by the method of Lepoivre 
et al., 1990. To 0.5 ml of cell lysate, 0.1 ml of sulfosalicylic acid was 
added and vortexed well for 30 min. The samples were then centrifuged 
at 5000 rpm for 15 min. The protein-free supernatant was used for the 
estimation of nitrite levels. To 200 μl of the supernatant, 30 μl of 10% 
NaOH was added, followed by 300 μl of Tris-HCl buffer and mixed well. 
To this, 530 μl of Griess reagent was added and incubated in the dark 
for 10–15 min, and the absorbance was read at 540 nm against a Griess 
reagent blank. Sodium nitrite solution was used as the standard [19,22].
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The cell viability curve of RAW 264.7 cells treated with varying 
concentrations of ESBE of K. attenuata is displayed in Fig. 1. The extract 
was found to be nontoxic with an IC50 value >250 μg/ml.
In vivo pharmacological activity
Carrageenan-induced paw edema in rats
Carrageenan-induced paw edema is a model for evaluating acute anti-
inflammatory activity. The subplantar injection of carrageenan in 
control rats (n=6) induced a time-dependent increase in paw volume, 
which peaked at 3rd h (1.25±0.02). Treatment with ESBE (250 and 
500 mg/kg p.o) 1 h before carrageenan administration resulted in a 
dose-dependent reduction in paw edema providing the maximum effect 
(60.83%) at the dose of 500 mg/kg. Indomethacin (10 mg/kg) has also 
suppressed carrageenan-induced increase in paw volume at the 4th h 
with an inhibition percentage of 70.63%.
Cotton pellet granuloma method
Implantation of cotton pellets resulted in the formation of 
granulomatous tissue in all experimental groups (Fig. 3). Fig. 4 
shows the average dry weight of the cotton pellets removed from 
rats, which indicate a reduction in granuloma tissue formation 
due to the treatment with both standard drug dexamethasone and 
the ESBE of K. attenuata. The percentage inhibition of granuloma 
tissue formation by test extract (500 mg/kg) was comparable to that 
obtained from standard and was found to be 41.28% and 52.73%, 
respectively.
In vitro anti-inflammatory studies
In vitro anti-inflammatory activity in cell lines
COX inhibition assay
COX-1 and COX-2 are an enzyme that is responsible for the formation 
of prostaglandins during acute inflammation. The percentage COX 
inhibition by diclofenac sodium (standard) and different concentrations 
of ESBE is presented in Fig. 5. ESBE (100 μg/ml) and diclofenac sodium 
(standard, 10 μg/ml) showed a percentage inhibition of COX activity by 
51.83% and 61.33%, respectively.
LOX inhibitory assay
5-Lipoxygenase is an enzyme that is involved in the production of 
leukotrienes (an inflammatory mediator). Inhibition of 5-lipoxygenase 
by ESBE of K. attenuata was observed to be not significant as compared 
to that of standard.
Estimation of MPO enzyme activity
Anti-inflammatory effect of extract was elucidated by the reduction 
in MPO enzyme activity which catalyzes the formation of free radicals 
secreted during inflammation. The decrease in MPO activity after 
treatment with diclofenac (standard) and different concentrations of 
extract is presented in Fig. 6. ESBE (100 μg/ml) showed an effect on par 
with that of standard, diclofenac.
Estimation of cellular nitrite level
The cellular nitrite level an indicator of nitric oxide free radical 
produced during inflammation was found to decrease with an 
increasing concentration of ESBE. The values obtained (Fig. 7) showed 
a comparable effect with that of standard (sodium nitrite).
DISCUSSION
Medicinal plants are a rich source of natural compounds that 
offer significant therapeutic potential for treating various disease 
conditions. Many of them are used in folk medicine with or without a 
proper scientific basis. The ethnopharmacological use of stem bark of 
plant K. attenuata in inflammatory conditions has been described by 
Ravikumar and Ved (2000). To establish a scientific basis for the anti-
inflammatory action of ESBE of K. attenuata, various in vivo and in vitro 
screening techniques were applied in this study.
Fig. 1: Cell viability curve of RAW 264.7 cells exposed to varying 
concentrations of ethanolic stem bark extract. n=3; values were 
expressed in mean±standard error of the mean. RAW 264.7 cells 
were activated with 1 μg/ml of LPS
Fig. 2: Comparison of paw volume of groups at different time 
intervals n=6; values were expressed in mean±standard error of 
the mean; indomethacin 10 mg/kg, ethanolic stem bark extract 
250 mg/kg, and 500 mg/kg were compared to control; one-way 
ANOVA followed by Dunnett’s t-test. p<0.001 compared to control 
at 4th h
Fig. 3: Photographs (a-d) showing cotton pellet-induced 
granuloma in the axilla region of rats and (e) cotton pellet 
removed after animal sacrifice
Fig. 4: Comparison of average dry weight of cotton 
pellets removed from rats. n=6, Values were expressed in 
mean±standard error of the mean. Ethanolic stem bark extract 
(ESBE) 250 mg/kg and 500 mg/kg was compared to control; one-
way ANOVA followed by Dunnett’s t-test. ESBE treated groups; 
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Study of acute phase of inflammation was carried out using carrageenan-
induced paw edema, a standard in vivo model that screens anti-inflammatory 
agents which act by inhibiting mediators of acute inflammation [17]. 
Carrageenan-induced rat paw edema is a biphasic response in which the 
early phase involves mast cell degranulation, histamine, and serotonin 
release (1–2 h) and further bradykinin release and pain followed by 
prostaglandin production in the later phase (3–4 h) [23,24]. Since the 
edema produced is known to be sensitive to COX, the non-steroidal anti-
inflammatory agents which are COX inhibitors of prostaglandin synthesis 
were used as standards for this assessment [25]. In this study, oral 
administration of ESBE showed antiedemal activity at both doses tested. 
Ethanolic extract (500 mg/kg) was more effective than its lower dose and 
showed a significant (p<0.0001) percentage inhibition of 60.83% with an 
added benefit of reduced toxicity compared to indomethacin (standard), 
which provided 70.63% but caused adverse effects. Both indomethacin 
and ethanolic extract showed inhibition of increase in paw volume at the 
4th h indicating their similar mechanism of action.
The cotton pellet-induced granuloma was used to determine the 
transudative and proliferative components of subacute inflammation. 
The weight of dry cotton pellets correlates with the amount of 
granulomatous tissue formed. Dexamethasone was taken as 
reference standard as steroidal drugs have shown more inhibition 
on the granuloma formation compared to NSAIDs [26]. In this 
study, the administration of K. attenuata extract (250 mg/kg and 
500 mg/kg, p.o.) inhibited the granuloma formation in a dose-
dependent manner indicating an effective suppression of proliferative 
phase of inflammation by the extract.
According to ISO 10993, biocompatibility of any agent should be first 
evaluated using in vitro cytotoxicity test, and further tests in laboratory 
animals (in vivo) could be carried out only if proved to be nontoxic [27]. 
In cell viability testing using MTT assay method, ESBE showed an IC50 
>250 μg/ml indicating a low cell toxicity.
In vitro screening techniques are a faster, simpler, and more predictive 
alternative to in vivo techniques that can be used to elucidate the possible 
mechanisms involved in the anti-inflammatory action expressed by the 
extract. RAW 264.7 a murine macrophage cell line was employed for 
screening anti-inflammatory action in vitro [15].
In vitro anti-inflammatory activity of ESBE was determined using cell 
lines, which confirmed the results obtained from in vivo experiments. 
Anti-inflammatory assay techniques such as COX inhibitory assay, LOX 
inhibitory assay, estimation of MPO activity, and estimation of cellular 
nitrite level were carried out on cell lysate to determine the possible 
mechanisms behind the action shown by extract.
COX and LOX are two enzymes involved in arachidonic pathway that 
triggers inflammation. The exact mechanism of inhibition of COX 
and LOX enzymes by natural products is not elucidated. Since both 
pathways include free radical reactions, due to their radical scavenging 
activity or reducing properties, many plant natural products can 
interfere with reactions catalyzed by COX and LOX, neutralize radical 
intermediates and thus terminates the reaction. Otherwise, they can 
reduce Fe3+ ion, which is a part of active site of both enzymes and is 
necessary for initiation reaction. The differences in COX and LOX 
inhibitions would be due to the differences in reaction mechanism and 
active site three-dimensional structures [28]. K. attenuata contains 
flavonoids and saponins for which antioxidant activity has been 
already established [29]. The ethanolic extract showed significant COX 
inhibition activity in LPS-stimulated RAW 264.7 macrophage cells with 
a percentage inhibition of 51.09%, respectively.
Accumulation of neutrophils and macrophages at the site of inflammation 
is a prominent feature in inflammatory processes. Therefore, their 
quantification in inflamed tissue using MPO enzyme estimation method 
can be useful for predicting the intensity of inflammation. MPO enzyme 
catalyzes the formation of reactive oxygen species and is secreted 
during inflammation [30]. In this study, both diclofenac and 100 μg 
ESBE of K. attenuata exhibited a decrease in the MPO activity to similar 
levels (0.0023 and 0.0032 units/mg, respectively) and suggested that 
inhibition of leukocyte infiltration can also be a mechanism by which 
the extract exhibits its anti-inflammatory properties.
In the next method, the cellular nitrite level an indicator of nitric oxide 
free radical produced during inflammation was found to decrease with 
an increase in the concentration of ethanolic extract [15]. 100 μg/ml of 
ethanolic extract was comparable with that of the standard (347.49 μg 
and 339.94 μg, respectively).
The in vivo and in vitro methods have provided much scientific evidence 
for the traditional use of stem bark of K. attenuata for the treatment 
of inflammatory conditions. The anti-inflammatory action exhibited by 
the extract was due to inhibition of leukocyte migration and NO pathway 
and partially by inhibition of mediators such as prostaglandins. The 
anti-inflammatory action of the ESBE can be attributed to the presence 
of flavonoids and polyphenolic compounds identified in the preliminary 
phytochemical analysis of extract.
Fig. 5: Comparison of percentage inhibition of cyclooxygenase 
activity. n=3, values were expressed in mean±standard error of 
the mean. p<0.0001, Optical density of standard and ethanolic 
stem bark extract (100 μg/ml) was compared with control (one-
way ANOVA followed by Dunnett’s t-test)
Fig. 6: Comparison of decrease in myeloperoxidase enzyme 
activity. n=3, values were expressed in mean±standard error of 
the mean. p<0.0001, optical density of standard and ethanolic 
stem bark extract (100 μg/ml) were compared with control (one-
way ANOVA followed by Dunnett’s t-test)
Fig. 7: Comparison of cellular nitrite level. n=3, values were 
expressed in mean±standard error of the mean. p<0.0001, 
optical density of standard and ethanolic stem bark extract 
(100 μg/ml) were compared with control (one-way ANOVA 
followed by Dunnett’s t-test)
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This study showed that stem bark extract of K. attenuata possesses 
promising anti-inflammatory activity in both in vitro and in vivo 
conditions. Further detailed study is recommended to determine 
the active constituents present in the extract so that researches on 
other pharmacological activities of stem bark of K. attenuata can be 
conducted.
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